Full Press Release Details
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, April 04, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will participate in the following investor conferences in April:
23rd Annual Needham Virtual Healthcare Conference – Presenting a company overview on Thursday, April 11, 2024, at 3:45 p.m. ET
Stifel Virtual Targeted Oncology Forum – Participating in a virtual fireside chat on Wednesday, April 17, 2024, at 12:30 p.m. ET.
Webcasts of the presentation and discussion will be available through the investor section of the company’s website at www.oricpharma.com. Replays of the webcasts will be available for 90 days following the events.
About ORIC Pharmaceuticals, Inc.
Dominic Piscitelli, Chief Financial Officer